Liver Stiffness Better Reflects Cumulative Hepatic Injury Than Iron Concentration in Thalassemia

The clinical management of transfusion-dependent thalassemia has transitioned from a focus on acute survival to the long-term mitigation of multi-organ complications. While iron chelation therapy has significantly improved life expectancy, chronic iron overload remains a primary driver of progressive liver fibrosis and eventual cirrhosis [1, 2]. This risk is frequently compounded by historical viral hepatitis and emerging metabolic dysfunction-associated steatotic liver disease, which act synergistically to promote hepatic injury [3]. Although magnetic resonance imaging has become the standard for quantifying liver iron concentration (a non-invasive measurement of the total iron stored within hepatic tissue), these measurements provide a temporal snapshot that may not fully reflect the cumulative architectural damage caused by sustained oxidative stress [2, 4]. Furthermore, the complex interplay between iron-related toxicity and systemic inflammation underscores the need for non-invasive tools that can more accurately stage fibrosis to guide therapeutic intensity [5, 6]. A recent study now provides critical evidence on how elastography-based stiffness measurements can refine the clinical assessment of these high-risk patients.